Genipin derivative having anti hepatitis B virus activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 19, 2000
Grant Date -
N/A
app pub date -
Apr 14, 1999
filing date -
Oct 18, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a novel genipin derivative represented by formula (I), which has anti hepatitis B virus (HBV) activity, in which R.sub.1 represents lower alkyl, benzyl, etc., R.sub.2 represents hydroxymethyl, formyl, acetyl, etc., R.sub.3 represents methoxycarbonyl, formyl, etc., its pharmaceutically acceptable salt, and stereoisomer. ##STR1##
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully